T1	PROC 19 81	Estudio de fase 2, multicéntrico, aleatorizado, en doble ciego
T2	PROC 181 212	evaluar la eficacia y seguridad
T3	CHEM 216 222	TF0023
T4	PROC 232 239	placebo
#1	AnnotatorNotes T4	C0032042; Placebos; Therapeutic or Preventive Procedure
T5	PROC 246 257	tratamiento
#2	AnnotatorNotes T5	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T6	DISO 264 272	COVID-19
#3	AnnotatorNotes T6	C5203670; COVID19 (disease); Disease or Syndrome
T7	LIVB 276 283	adultos
#4	AnnotatorNotes T7	C0001675; Adult; Age Group
T8	Age 276 283	adultos
T9	PROC 284 298	hospitalizados
#5	AnnotatorNotes T9	C0019993; Hospitalization; Health Care Activity
T10	PROC 316 333	Estudio de fase 2
T11	PROC 339 370	evaluar la eficacia y seguridad
T12	CHEM 374 380	TF0023
T13	PROC 390 397	placebo
#6	AnnotatorNotes T13	C0032042; Placebos; Therapeutic or Preventive Procedure
T14	PROC 404 415	tratamiento
#7	AnnotatorNotes T14	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T15	DISO 422 430	COVID-19
#8	AnnotatorNotes T15	C5203670; COVID19 (disease); Disease or Syndrome
T16	LIVB 434 441	adultos
#9	AnnotatorNotes T16	C0001675; Adult; Age Group
T17	Age 434 441	adultos
T18	PROC 442 456	hospitalizados
#10	AnnotatorNotes T18	C0019993; Hospitalization; Health Care Activity
T19	DISO 470 492	Infección por COVID-19
#11	AnnotatorNotes T19	C5203670; COVID19 (disease); Disease or Syndrome
T20	PROC 520 533	Hospitalizado
#12	AnnotatorNotes T20	C0019993; Hospitalization; Health Care Activity
T21	DISO 538 569	síntomas pulmonares de COVID-19
T22	LIVB 583 591	paciente
#13	AnnotatorNotes T22	C0030705; Patients; Patient or Disabled Group
T23	LIVB 598 617	representante legal
T24	PROC 629 653	consentimiento informado
#14	AnnotatorNotes T24	C0567423; Informed consent for procedure; Therapeutic or Preventive Procedure
T25	PROC 678 703	procedimiento del estudio
T26	PROC 729 755	procedimientos del estudio
T27	LIVB 770 775	Varón
T28	LIVB 778 783	mujer
#15	AnnotatorNotes T28	C0043210; Woman; Population Group | C0242665; wife; Family Group
T29	Neg_cue 784 786	no
T30	PHYS 787 797	embarazada
#16	AnnotatorNotes T30	C0032961; Pregnancy; Organism Function
T31	LIVB 799 805	adulto
#17	AnnotatorNotes T31	C0001675; Adult; Age Group
T32	Age 799 805	adulto
T33	Age 806 816	>/=18 años
T34	DISO 868 944	infección por el coronavirus del síndrome respiratorio agudo grave de tipo 2
T35	LIVB 946 956	SARS-CoV-2
#18	AnnotatorNotes T35	C5203676; SARS-CoV-2; Virus
T36	PROC 997 1032	reacción en cadena de la polimerasa
#19	AnnotatorNotes T36	C0032520; Polymerase Chain Reaction; Molecular Biology Research Technique
T37	PROC 1034 1059	polymerase chain reaction
T38	PROC 1061 1064	PCR
#20	AnnotatorNotes T38	C0032520; Polymerase Chain Reaction; Molecular Biology Research Technique | C0201657; C-reactive protein measurement; Laboratory Procedure
T39	Neg_cue 1110 1112	no
T40	PROC 1129 1138	serología
#21	AnnotatorNotes T40	C0036743; Serologic tests; Laboratory Procedure
T41	Negated 1129 1138	serología
T42	DISO 1172 1181	trastorno
#22	AnnotatorNotes T42	C0012634; Disease; Disease or Syndrome
T43	LIVB 1331 1339	paciente
#23	AnnotatorNotes T43	C0030705; Patients; Patient or Disabled Group
T44	LIVB 1460 1472	investigador
#24	AnnotatorNotes T44	C0035173; Research Personnel; Professional or Occupational Group
T45	PROC 1489 1527	oxigenación por membrana extracorpórea
#25	AnnotatorNotes T45	C0015357; Extracorporeal Membrane Oxygenation; Therapeutic or Preventive Procedure
T46	PROC 1564 1568	alta
#26	AnnotatorNotes T46	C0030685; Patient Discharge; Health Care Activity
T47	PROC 1584 1608	traslado a otro hospital
T48	Neg_cue 1609 1611	no
T49	LIVB 1612 1624	participante
T50	Negated 1612 1624	participante
T51	Negated 787 797	embarazada
T52	PROC 111 174	controlado con placebo, de grupos paralelos y búsqueda de dosis
T53	DISO 1210 1244	proceso médico o neuropsiquiátrico
T54	DISO 1285 1309	anomalías de laboratorio
T55	PROC 1438 1445	estudio
T56	PROC 1631 1638	estudio
T57	Quantifier_or_Qualifier 570 576	activa
T58	Observation 706 743	acepta cumplir con los procedimientos
T59	CONC 845 854	inclusión
T60	Quantifier_or_Qualifier 1116 1125	aceptable
T61	Observation 1210 1224	proceso médico
T62	Quantifier_or_Qualifier 1245 1258	significativo
T63	Observation 1285 1309	anomalías de laboratorio
T64	Observation 1343 1349	riesgo
T65	Observation 1365 1390	participase en el estudio
T66	CONC 1534 1547	momento basal
T67	Observation 1612 1638	participante en el estudio
T68	Patient 276 283	adultos
T69	Patient 434 441	adultos
T70	Patient 583 591	paciente
T71	Other 598 617	representante legal
T72	Patient 770 775	Varón
T73	Patient 778 783	mujer
T74	Patient 799 805	adulto
T75	Patient 1331 1339	paciente
T76	Other 1460 1472	investigador
T77	Future 1564 1581	alta del hospital
T78	Future 1584 1608	traslado a otro hospital
